Replies to post #146 on RxElite, Inc. (RXEI)

[TOXX]

The site in Israel is an API (Active Pharmaceutical Ingredient) manufacturer. They intend to use this site to manufacture the API for the drug products (yet to be approved) made in the states. I’m suspect the site in Israel also manufactures API for other companies but that's not where the money is. Their pending ANDA applications are still in the very preliminary stages of review. Commercial production, if the application(s) are approved, is at a minimum of 2 years away.